BouNDless: An active-controlled randomized, double-blind double-dummy study of continuous ND0612 infusion in patients with fluctuating Parkinson's disease

被引：0
|
作者：
Poewe, W.
Kieburtz, K.
Stocchi, F.
Oren, S.
Yardeni, T.
Adar, L.
Rosenfeld, O.
Olanow, C.
机构：
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
179
引用
收藏
页码：S74 / S74
页数：1
相关论文
共 50 条
  • [21] A Double-Blind, Randomized, Placebo and Active-Controlled Study of Nebicapone for the Treatment of Motor Fluctuations in Parkinson's Disease
    Ferreira, Joaquim J.
    Rascol, Olivier
    Poewe, Werner
    Sampaio, Cristina
    Rocha, Jose-Francisco
    Nunes, Teresa
    Almeida, Luis
    Soares-da-Silva, Patricio
    CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (06) : 337 - 347
  • [22] Randomized, double-blind, double-dummy study of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: efficacy analyses by subgroups
    Antonini, A.
    Chatamra, K.
    Robieson, W. Z.
    Pritchett, Y.
    Widnell, K. L.
    Benesh, J.
    Lenz, R. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 291 - 291
  • [23] Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
    Poewe, Werner H.
    Rascol, Olivier
    Quinn, Niall
    Tolosa, Eduardo
    Oertel, Wolfgang H.
    Martignoni, Emilia
    Rupp, Markus
    Boroojerdi, Babak
    LANCET NEUROLOGY, 2007, 6 (06) : 513 - 520
  • [24] Randomized, Double-Blind, Double-Dummy Study of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Efficacy Analyses by Subgroups
    Antonini, Angelo
    Chatamra, Krai
    Robieson, Weining
    Pritchett, Yili
    Widnell, Katherine
    Benesh, Janet
    Lenz, Robert
    NEUROLOGY, 2013, 80
  • [25] Primary results of DECIDE: a randomized, double-blind, double-dummy, active-controlled trial of daclizumab HYP vs. Interferon β-1a in RRMS patients
    Kappos, L.
    Selmaj, K.
    Arnold, D. L.
    Havrdova, E.
    Boyko, A.
    Kaufman, M.
    Wiendl, H.
    Rose, J.
    Greenberg, S.
    Demirhan, E.
    Sweetser, M.
    Riester, K.
    Elkins, J.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 38 - 38
  • [26] Entacapone to tolcapone switch study: Multicenter double-blind, randomized, active-controlled trial in advanced Parkinson's disease
    Agid, Y
    Oertel, W
    Factor, S
    MOVEMENT DISORDERS, 2005, 20 : S94 - S94
  • [27] A double-blind double-dummy study of citalopram comparing infusion versus oral administration
    Baumann, P
    Nil, R
    Bertschy, G
    Jecker, A
    Brändli, H
    Morand, J
    Kasas, A
    Vuagniaux, O
    Ramseier, F
    JOURNAL OF AFFECTIVE DISORDERS, 1998, 49 (03) : 203 - 210
  • [28] Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study
    Hosoya, T.
    Ogawa, Y.
    Hashimoto, H.
    Ohashi, T.
    Sakamoto, R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (03) : 290 - 297
  • [29] Subcutaneous foslevodopa/foscarbidopa in patients with advanced Parkinson's Disease: results from a randomized, double-blind, double-dummy phase 3 trial
    Soileau, M.
    Spindler, M.
    Aldred, J.
    Budur, K.
    Fisseha, N.
    Fung, V.
    Jeong, A.
    Kimber, T.
    Klos, K.
    Litvan, I.
    O'Neill, D.
    Robieson, W.
    Standaert, D.
    Talapala, S.
    Vaou, E. Okeanis
    Zheng, H.
    Facheris, M.
    Hauser, R.
    MOVEMENT DISORDERS, 2022, 37 : S354 - S354
  • [30] Subclinical affective and cognitive fluctuations in Parkinson's disease: a randomized double-blind double-dummy study of Oral vs. Intrajejunal Levodopa
    Jaime Kulisevsky
    Helena Bejr-Kasem
    Saul Martinez-Horta
    Andrea Horta-Barba
    Berta Pascual-Sedano
    Antonia Campolongo
    Juan Marín-Lahoz
    Ignacio Aracil-Bolaños
    Jesús Pérez-Pérez
    Cristina Izquierdo-Barrionuevo
    Oriol de Fàbregues
    Victor Puente
    Ane Crespo-Cuevas
    Matilde Calopa
    Javier Pagonabarraga
    Journal of Neurology, 2020, 267 : 3400 - 3410
12345